Ganesha Moorthy

Response surface methodology approach for optimization of lead(II) adsorptive removal by Spirogyra sp. biomass

N. Sivarajasekar, S. Sivamani, N. Mohanraj, 2017 .

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors

S. Barry, G. Shapiro, C. Higano, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Reversible carboxamide-mediated internal activation at C(6) of 2-chloro-4-anilino-1H-pyrrolo[2,3-d]pyrimidines.

K. Stevens, Joseph W. Wilson, S. Patnaik, 2008, The Journal of organic chemistry.

Abstract CT007: PETRA: First in class, first in human trial of the next generation PARP1-selective inhibitor AZD5305 in patients (pts) with BRCA1/2, PALB2 or RAD51C/D mutations

S. Luen, A. Schram, M. Schwaederlé, 2022, Cancer Research.

Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors

C. Drake, J. Bendell, D. George, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma

A. Oza, G. Fabbri, J. Saeh, 2023, Molecular cancer therapeutics.